|
Dr. Paul Plourde, VP of Clinical and Regulatory Affairs, gained his medical degree from the University of Vermont. He did his post-graduate clinical training at Penn State University and holds board certification in both internal medicine and endocrinology. Dr. Plourde has over 20 years of drug development experience at AstraZeneca where he held numerous senior positions of responsibility, most recently as a VP of Clinical Oncology Development. Most of his time in the industry has been gained in oncology where he helped develop several key products for the treatment of breast and prostate cancer. | 